Reasons for avoidance of bevacizumab with first-line FOLFOX for advanced colorectal cancer

✍ Scribed by Natsuko Hori, Satoru Iwasa, Hironobu Hashimoto, Takako Yanai, Ken Kato, Tetsuya Hamaguchi, Yasuhide Yamada, Kouji Murakoshi, Nobuaki Yokote, Hiroshi Yamamoto, Yasuhiro Shimada…show all 11hide

• Book ID: 120962066
• Publisher: Springer
• Year: 2012
• Tongue: English
• Weight: 179 KB
• Volume: 18
• Category: Article
• ISSN: 1341-9625
• DOI: 10.1007/s10147-012-0398-4